SJRI | St. John's Research Institute

Projects

Heart Outcomes Prevention Evaluation - 3 Study (HOPE-3)

Division Clinical Research and Training Year 2008

Project Lead Dr. Prem Pais, Dr. Denis Xavier Source of Funding Population Health Research Institute, Canadian Institutes of Health Research, AstraZeneca

Details

An RCT to evaluate the safety and efficacy of rosuvastatin and candesartan / hydrochlorothiazide and their combinations in middle aged people who are at an intermediate risk for vascular events.